Compugen Ltd

NASDAQ:CGEN   3:59:54 PM EDT
13.04
-0.47 (-3.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

COMPUGEN LTD Stock, NASDAQ:CGEN

26 HAROKMIM STREET, BUILDING D, HOLON, ISRAEL 5885849
Phone: 011-972-3-765-8585
Number of Employees: 98

Description

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company's pipeline primarily includes early and preclinical stage immuno-oncology programs based on novel drug targets, such as immune checkpoint and myeloid protein target candidates to harness the immune system to provide treatment solutions in the areas of unmet medical needs in various cancer types and patient populations. Its antibody drug conjugate target candidates comprise CGEN-15001T, CGEN-15022, CGEN-15029, and CGEN-15137 for oncology; and therapeutic proteins include CGEN-15001, a fusion protein for autoimmune diseases, as well as CGEN myeloid target. The company was incorporated in 1993 and is headquartered in Holon, Israel.